Stay updated with breaking news from Fatty Liver Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Madrigal Pharmaceuticals announced resmetirom is available in the US beginning on April 9, 2024, ushering in a new era of NASH management.
Better Therapeutics, Inc. , a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announced it has submitted a request to the U.S. Food and Drug...
New analyses from the phase 3 MAESTRO-NASH support the oral daily drug's benefit for cardiovascular and hormonal outcomes over 1 year.
The international group behind the new terminology worked for 3 years to build a consensus, but convincing their peers to adopt it will require more effort.
Ozempic is a master mimicker of the hormone GLP-1, which helps the pancreas release insulin. It also acts on the brain to reduce hunger.